Your browser doesn't support javascript.
loading
Use of Nintedanib and Pirfenidone in Non-Idiopathic Pulmonary Fibrosis Lung Disease.
Warrior, Krishnan; Chung, Paul A; Reid, Michal; Bemiss, Bradford C.
Affiliation
  • Warrior K; Division of Pulmonary and Critical Care, Loyola University Medical Center, Maywood, Illinois.
  • Chung PA; Division of Pulmonary and Critical Care, Loyola University Medical Center, Maywood, Illinois.
  • Reid M; Division of Pulmonary and Critical Care, Loyola University Medical Center, Maywood, Illinois.
  • Bemiss BC; Division of Pulmonary and Critical Care, Loyola University Medical Center, Maywood, Illinois.
Am J Respir Crit Care Med ; 204(1): 92-94, 2021 07 01.
Article in En | MEDLINE | ID: mdl-33951400

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Lung Diseases Limits: Humans Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Lung Diseases Limits: Humans Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2021 Document type: Article